KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma

Two-pore-domain (KCNK, K2P) K+ channels are transmembrane protein complexes that control the flow of ions across biofilms, which underlie many essential cellular functions. Because KCNK family members are known to contribute to tumorigenesis in various types of cancer, we hypothesized that they might be differentially expressed in hepatocellular carcinoma (HCC) cells as compared to healthy tissue and serve as diagnostic or prognostic biomarkers. We tested this hypothesis through bioinformatic analyses of publicly available data for the expression of various KCNK subunits in HCC. We observed reduced expression of KCNK2, KCNK15, and KCNK17 in liver cancer, as well as overexpression of KCNK9, all of which correlated with a better prognosis for HCC patients per survival analyses. Moreover, ROC curves indicated that KCNK2, KCNK9, KCNK15, and KCNK17 levels could be used as a diagnostic biomarker for HCC. Finally, our western blot and qRT-PCR results were consistent with those obtained from bioinformatic analyses. Taken together, these results suggest that KCNK2, KCNK9, KCNK15, and KCNK17 could serve as potential diagnostic and prognostic biomarkers of HCC.

[1]  R. Lifton,et al.  Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma , 2017, The Journal of clinical investigation.

[2]  K. O’Shaughnessy,et al.  Both TASK-3 and TREK-1 two-pore loop K channels are expressed in H295R cells and modulate their membrane potential and aldosterone secretion. , 2008, American journal of physiology. Endocrinology and metabolism.

[3]  M. Wigler,et al.  Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. , 2003, Cancer cell.

[4]  Dongling Yang,et al.  FXYD6: a novel therapeutic target toward hepatocellular carcinoma , 2014, Protein & Cell.

[5]  Detlef Bockenhauer,et al.  Potassium leak channels and the KCNK family of two-p-domain subunits , 2001, Nature Reviews Neuroscience.

[6]  Jun Liu,et al.  Identification of Crucial Genes Associated With Immune Cell Infiltration in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis , 2020, Frontiers in Genetics.

[7]  H. Kwan,et al.  Blockage of voltage-gated K+ channels inhibits adhesion and proliferation of hepatocarcinoma cells. , 2003, International journal of molecular medicine.

[8]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[9]  G. Gores,et al.  Hepatocellular carcinoma: clinical frontiers and perspectives , 2014, Gut.

[10]  D. Lotshaw.  Biophysical, pharmacological, and functional characteristics of cloned and native mammalian two-pore domain K+ channels , 2007, Cell Biochemistry and Biophysics.

[11]  E. Honoré,et al.  The neuronal background K2P channels: focus on TREK1 , 2007, Nature Reviews Neuroscience.

[12]  Q. Ding,et al.  Transmembrane channel-like protein 8 as a potential biomarker for poor prognosis of hepatocellular carcinoma. , 2017, Molecular and clinical oncology.

[13]  M. Lazdunski,et al.  Genomic and functional characteristics of novel human pancreatic 2P domain K(+) channels. , 2001, Biochemical and biophysical research communications.

[14]  L. Csernoch,et al.  Mitochondrial expression of the two-pore domain TASK-3 channels in malignantly transformed and non-malignant human cells , 2008, Virchows Archiv.

[15]  Hao Chen,et al.  The potassium channel KCa3.1 promotes cell proliferation by activating SKP2 and metastasis through the EMT pathway in hepatocellular carcinoma , 2019, International journal of cancer.

[16]  Mapping of human potassium channel genes TREK-1 (KCNK2) and TASK (KCNK3) to chromosomes 1q41 and 2p23. , 1998, Genomics.

[17]  Chao Wu,et al.  ASIC1a mediates the drug resistance of human hepatocellular carcinoma via the Ca2+/PI3-kinase/AKT signaling pathway , 2016, Laboratory Investigation.

[18]  P. Stanfield,et al.  TASK-5, a novel member of the tandem pore K+ channel family , 2001, Pflügers Archiv.

[19]  C. Cordon-Cardo,et al.  TREK-1 is a novel molecular target in prostate cancer. , 2008, Cancer research.

[20]  Y. Wan,et al.  Decreased abundance of TRESK two-pore domain potassium channels in sensory neurons underlies the pain associated with bone metastasis , 2018, Science Signaling.

[21]  John P. Overington,et al.  How many drug targets are there? , 2006, Nature Reviews Drug Discovery.

[22]  Chad J. Creighton,et al.  UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses , 2017, Neoplasia.

[23]  Fei Zou,et al.  ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity. , 2009, Carcinogenesis.

[24]  A. Villanueva,et al.  Liver capsule: Molecular‐based signatures in hepatocellular carcinoma , 2016, Hepatology.

[25]  P. Purhonen,et al.  Structure of potassium channels , 2015, Cellular and Molecular Life Sciences.

[26]  Lewis J. Watson,et al.  The two-pore domain potassium channel TREK-1 mediates cardiac fibrosis and diastolic dysfunction , 2018, The Journal of clinical investigation.

[27]  M. Borggrefe,et al.  Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation , 2015, Circulation.

[28]  Y. Miao,et al.  ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation , 2018, Cellular Physiology and Biochemistry.

[29]  Péter Enyedi,et al.  Molecular Background of Leak K (cid:1) Currents: Two-Pore Domain Potassium Channels , 2010 .

[30]  Mansoor Abdul,et al.  Expression and activity of potassium ion channels in human prostate cancer. , 2002, Cancer letters.

[31]  L. Pardo,et al.  Overexpression of Eag1 potassium channels in clinical tumours , 2006, Molecular Cancer.

[32]  D. Minor,et al.  K2P2.1(TREK-1):activator complexes reveal a cryptic selectivity filter binding site , 2017, Nature.

[33]  Wei Liu,et al.  Hypermethylated KCNQ1 acts as a tumor suppressor in hepatocellular carcinoma. , 2018, Biochemical and biophysical research communications.

[34]  S. Goldstein,et al.  ORK1, a potassium-selective leak channel with two pore domains cloned from Drosophila melanogaster by expression in Saccharomyces cerevisiae. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Donghee Kim,et al.  TASK-3, a New Member of the Tandem Pore K+ Channel Family* , 2000, The Journal of Biological Chemistry.

[36]  H. Sowter,et al.  Expression and effects of modulation of the K2P potassium channels TREK-1 (KCNK2) and TREK-2 (KCNK10) in the normal human ovary and epithelial ovarian cancer , 2013, Clinical and Translational Oncology.

[37]  P. Jonsson,et al.  The two-pore domain potassium channel KCNK5: induction by estrogen receptor alpha and role in proliferation of breast cancer cells. , 2011, Molecular endocrinology.

[38]  W. Park,et al.  Altered expression of KCNK9 in colorectal cancers , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.